We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00269867
Recruitment Status : Completed
First Posted : December 26, 2005
Last Update Posted : November 4, 2014
Information provided by (Responsible Party):
Centocor, Inc.